Genetic variants in interleukin-2 and risk of lymphoma among children in Korea

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 2, 2012, Pages 621-623

  Song, Nan ^a   Han, Sohee ^b   Lee, Kyoung Mu ^c   Choi, Ji Yeob ^b   Park, Sue K ^b   Jeon, Sujee ^a   Lee, Yunhee ^b   Ahn, Hyo Seop ^b,d   Shin, Hee Young ^b,d   Kang, Hyoung Jin ^b,d   Koo, Hong Hoe ^e   Seo, Jong Jin ^f   Choi, Ji Eun ^g   Kang, Daehee ^b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea National Open University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Seoul National University Boramae Hospital   (South Korea)

Author keywords

Childhood lymphoma; Genetic variation; IL2; Korea

Indexed keywords

INTERLEUKIN 2;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INFANT; LYMPHOMA; MALE; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-2; LYMPHOMA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84866441802     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.2.621     Document Type: Article

References (10)

1. Baris S, Celkan T, Batar B, et al (2009). Association between genetic polymorphism in DNA repair genes and risk of B-cell lymphoma. Pediatr Hematol Oncol, 26, 467-72.
2. Cerhan JR, Wang S, Maurer MJ, et al (2007). Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood, 109, 5439-46.
3. Chan KK, Shen L, Au WY, et al (2010). Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells. J Pathol, 221, 164-74.
4. Chen BE, Sakoda LC, Hsing AW, et al (2006). Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol, 30, 495-507.
5. Cozen W, Gill PS, Salam MT, et al (2008). Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood, 111, 3377-82.
6. Howlader N, Noone AM, Krapcho M, et al(2011). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site.
7. Packer BR, Yeager M, Burdett L, et al (2006). SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res, 34, D617-21.
8. Rothman N, Skibola CF, Wang SS, et al (2006). Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol, 7, 27-38.
9. Seidemann K, Zimmermann M, Book M, et al (2005). Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM. 95, J Clin Oncol, 23, 8414-21.
10. Skinnider BF, Mak TW (2002). The role of cytokines in classical Hodgkin lymphoma. Blood, 99, 4283-97.